Why it’s time to rethink how we back health tech innovation

Written by: Melanie Davidson, Chief Executive Officer – Medilink Midlands

Medilink Midlands are a founding partner of Life Sciences Week

The UK health tech ecosystem has no shortage of brilliant ideas. But too often, innovators struggle not  because of science or ambition, but because the support system around them isn’t structured for scale.  Melanie Davidson, CEO of Medilink Midlands, argues that we need to move from tactical support to strategic  alignment—if we want to turn innovation into impact.  

Good ideas aren’t enough anymore – “Innovation isn’t the problem. The UK is world-class when it comes to  ideas,” says Melanie. “But I speak to too many companies who get stuck after the pilot, who can’t get  procurement to engage, or who don’t know how to navigate NHS adoption pathways.”  Melanie has seen this from all sides: policy, commercial, and delivery. With Medilink Midlands supporting  companies across diagnostics, digital health, medtech, and manufacturing, she’s aware of the hurdles SMEs  face.  

What ‘support’ should actually look like – “We often think of support as grants or advice,” she says, “but  what’s really needed is a coordinated strategy that links innovation, regulation, and reimbursement.”  

Melanie believes the next evolution of support must be multi-layered:  

  • Strategic guidance for navigating procurement and policy  
  • Business-critical partnerships with clinicians and academics  
  • Investor-readiness coaching to attract the right kind of capital  
  • Export-focused growth pathways to drive UK growth overseas.  

Medilink’s role: not just a connector – Melanie describes Medilink Midlands not just as a membership  network, but a catalyst – taking big ideas and helping them land with the right audiences, from funders to  frontline clinicians. “We help innovators see the whole journey – not just their next move.”  

This involves bespoke support, strategic insight, and representing industry views in national conversations on  medtech and life sciences policy, trade, and investment.  

We need to continue working with government, funders and strategic partners to make sure we think about  what companies need to survive, scale, and succeed – not just start.”  

For industry peers, she has this advice: “Work with people who get the full picture. Be open about what you  don’t know. Join the dots – because innovation doesn’t happen in silo.”

Leave A Comment

    Award Category Voting

    Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

    Categories you've not voted in, will be denoted with an ❌

    If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

    Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

    Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

    No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

    Awarding an individual or organisation for exceptional long-term impact on the industry.

    No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

    Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

    No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

    Your Details